Your browser doesn't support javascript.
loading
A Randomized Phase 2/3 Study of Ensitrelvir, a Novel Oral SARS-CoV-2 3C-Like Protease Inhibitor, in Japanese Patients with Mild-to-Moderate COVID-19 or Asymptomatic SARS-CoV-2 Infection: Results of the Phase 2a Part.
Mukae, Hiroshi; Yotsuyanagi, Hiroshi; Ohmagari, Norio; Doi, Yohei; Imamura, Takumi; Sonoyama, Takuhiro; Fukuhara, Takahiro; Ichihashi, Genki; Sanaki, Takao; Baba, Keiko; Takeda, Yosuke; Tsuge, Yuko; Uehara, Takeki.
Afiliação
  • Mukae H; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Yotsuyanagi H; The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Ohmagari N; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Doi Y; Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Imamura T; Departments of Microbiology and Infectious Diseases, Fujita Health University School of Medicine, Toyoake, Japan.
  • Sonoyama T; Drug Development and Regulatory Science Division, Shionogi & Co., Ltd., Osaka, Japan.
  • Fukuhara T; Drug Development and Regulatory Science Division, Shionogi & Co., Ltd., Osaka, Japan.
  • Ichihashi G; Drug Development and Regulatory Science Division, Shionogi & Co., Ltd., Osaka, Japan.
  • Sanaki T; Drug Development and Regulatory Science Division, Shionogi & Co., Ltd., Osaka, Japan.
  • Baba K; Pharmaceutical Research Division, Shionogi & Co., Ltd., Toyonaka, Japan.
  • Takeda Y; Pharmaceutical Research Division, Shionogi & Co., Ltd., Toyonaka, Japan.
  • Tsuge Y; Drug Development and Regulatory Science Division, Shionogi & Co., Ltd., Osaka, Japan.
  • Uehara T; Drug Development and Regulatory Science Division, Shionogi & Co., Ltd., Osaka, Japan.
Antimicrob Agents Chemother ; 66(10): e0069722, 2022 10 18.
Article em En | MEDLINE | ID: mdl-36098519
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tratamento Farmacológico da COVID-19 / Anti-Infecciosos Tipo de estudo: Clinical_trials Limite: Adult / Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tratamento Farmacológico da COVID-19 / Anti-Infecciosos Tipo de estudo: Clinical_trials Limite: Adult / Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2022 Tipo de documento: Article